Skip to main content
. 2022 Sep 20;14(9):e29354. doi: 10.7759/cureus.29354

Figure 16. Cancer stemness is required to maintain the myCAF phenotype in murine cancer models.

Figure 16

(A) In vivo imaging of bioluminescence labeled SK-Hep1 human liver cancer murine models at week; (B) bioluminescence intensity-based tumor growth curves; (C) immunohistochemistry assay of cancer stemness markers expression and myCAF markers expression in mice primary tumors; (D) cancer stemness markers mRNA expression and myCAF markers mRNA expression were quantified by real time PCR with mice primary tumor sorted cells.